Ensign Peak Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.63M | Sell |
|
|||||
|
2025
Q1 | $7.99M | Buy |
|
|||||
|
2024
Q4 | $7.06M | Hold |
|
|||||
|
2024
Q3 | $10.1M | Hold |
|
|||||
|
2024
Q2 | $8.04M | Hold |
|
|||||
|
2024
Q1 | $7.11M | Sell |
|
|||||
|
2023
Q4 | $7.48M | Hold |
|
|||||
|
2023
Q3 | $7.19M | Buy |
|
|||||
|
2023
Q2 | $4.38M | Buy |
|
|||||
|
2023
Q1 | $3.33M | Buy |
|
|||||
|
2022
Q4 | $3.96M | Buy |
|
|||||
|
2022
Q3 | $3.76M | Buy |
|
|||||
|
2022
Q2 | $2.52M | Sell |
|
|||||
|
2022
Q1 | $3.37M | Buy |
|
|||||
|
2021
Q4 | $4.66M | Buy |
|
|||||
|
2021
Q3 | $3.35M | Buy |
|
|||||
|
2021
Q2 | $3.29M | Buy |
|
|||||
|
2021
Q1 | $2.38M | Sell |
|
|||||
|
2020
Q4 | $4.85M | Buy |
|
|||||
|
2020
Q3 | $2.07M | Buy |
|
|||||
|
2020
Q2 | $1.39M | Sell |
|
|||||
|
2020
Q1 | $2.19M | Buy |
|
|||||
|
2019
Q4 | $139K | Buy |
|